Janney Montgomery Scott LLC grew its holdings in Agilent Technologies Inc (NYSE:A) by 13.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,315 shares of the medical research company’s stock after acquiring an additional 1,474 shares during the period. Janney Montgomery Scott LLC’s holdings in Agilent Technologies were worth $791,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Cubist Systematic Strategies LLC raised its position in shares of Agilent Technologies by 653.1% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 53,056 shares of the medical research company’s stock valued at $3,406,000 after purchasing an additional 46,011 shares during the period. Caxton Associates LP bought a new stake in shares of Agilent Technologies during the 3rd quarter valued at $225,000. Jane Street Group LLC raised its position in shares of Agilent Technologies by 8.8% during the 3rd quarter. Jane Street Group LLC now owns 18,145 shares of the medical research company’s stock valued at $1,165,000 after purchasing an additional 1,462 shares during the period. Chevy Chase Trust Holdings Inc. raised its position in shares of Agilent Technologies by 0.9% during the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 282,115 shares of the medical research company’s stock valued at $18,112,000 after purchasing an additional 2,599 shares during the period. Finally, First Allied Advisory Services Inc. bought a new stake in shares of Agilent Technologies during the 3rd quarter valued at $225,000.
In related news, insider Mark Doak sold 15,567 shares of Agilent Technologies stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $68.00, for a total transaction of $1,058,556.00. Following the completion of the transaction, the insider now directly owns 71,104 shares of the company’s stock, valued at approximately $4,835,072. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Michael R. Mcmullen sold 22,481 shares of Agilent Technologies stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $70.00, for a total transaction of $1,573,670.00. Following the transaction, the chief executive officer now directly owns 327,882 shares of the company’s stock, valued at $22,951,740. The disclosure for this sale can be found here. Insiders sold a total of 132,588 shares of company stock valued at $9,186,710 over the last three months.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.05. Agilent Technologies had a net margin of 14.89% and a return on equity of 15.04%. The business had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the company posted $0.59 EPS. The business’s revenue was up 7.0% on a year-over-year basis. equities research analysts predict that Agilent Technologies Inc will post 2.58 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd will be paid a $0.149 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date of this dividend is Friday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is presently 25.36%.
Several brokerages have recently commented on A. Goldman Sachs Group restated a “neutral” rating and set a $68.00 price objective on shares of Agilent Technologies in a research report on Tuesday, September 26th. Cowen reiterated a “hold” rating and issued a $65.00 price target on shares of Agilent Technologies in a report on Thursday, September 28th. Robert W. Baird reiterated a “buy” rating and issued a $72.00 price target on shares of Agilent Technologies in a report on Friday, November 24th. ValuEngine downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Finally, Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a report on Tuesday, October 31st. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Agilent Technologies currently has an average rating of “Buy” and a consensus target price of $68.34.
TRADEMARK VIOLATION WARNING: This news story was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.com-unik.info/2017/12/24/janney-montgomery-scott-llc-acquires-1474-shares-of-agilent-technologies-inc-a.html.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.